Delayed presentation of patients with posterior urethral valve with complications like severe urosepsis, uremia, and anemia are seen in our setting. Renal replacement therapy which should have been offered to these patients is not readily available for children in our country. The aim of this study is to determine the pattern of late presentation and outcome of management of posterior urethral valve in a resource-limited setting. A descriptive retrospective study (1997–2009) was conducted. Data including pattern of presentation, duration of symptoms, complications, and outcome of initial management were analyzed. Twenty-one patients were seen. The median age was 3 years (2 days–13 years). The mean duration of symptoms before presentation was 2.6 years. Nineteen patients (91%) presented with urosepsis while 8 patients (36%) presented with significant renal insufficiency. Laboratory findings varied from-mild-to marked elevation in serum creatinine. Radiological findings confirmed the diagnosis of posterior urethral valve. We concluded that late presentation is common in our setting. This is associated with high morbidity and mortality rates. Efforts at improving awareness and early diagnosis among the health team should be made to stem the tide. 1. Introduction Posterior urethral valves (PUV) are the commonest cause of lower urinary tract obstruction in male infants [1–3]. The incidence of this congenital anomaly in our setting is unknown, although reports from Unites States and Europe indicates that it occurs in about 1？:？8000 and 1？:？25,000 male live births [1, 3, 4]. Prolonged and unrelieved lower urinary tract obstruction leads to back pressure effects on the kidneys resulting in obstructive uropathy with renal impairment [5]. PUVs are also a common cause of chronic renal failure in children if treatment is delayed [6–8]. Late presentation in patients with PUV is associated with urosepsis, uremia, and anemia and these form the bulk of patients seen in our centre. Early diagnosis and prompt commencement of treatment is therefore germane to the overall outcome of these patients [9, 10]. This is particularly important in a resource—limited environment like ours where facilities for renal replacement therapy in children is not readily available. The aim of this study is to document the pattern of presentation in our centre and outcome of management. 2. Materials and Methods This is a retrospective descriptive study. Records of patients with PUV at the University of Nigeria Teaching Hospital (1997–2004) and Enugu State University of Technology Teaching
References
[1]
A. A. Nasir, E. A. Ameh, L. O. Abdur-Rahman, J. O. Adeniran, and M. K. Abraham, “Posterior urethral valve,” World Journal of Pediatrics, vol. 7, no. 3, pp. 206–216, 2011.
[2]
R. Imaji and P. A. Dewan, “The clinical and radiological findings in boys with endoscopically severe congenital posterior urethral obstruction,” British Journal of Urology International, vol. 88, no. 3, pp. 263–267, 2001.
[3]
J. D. Atwell, “Posterior urethral valves in the British Isles: a multicenter BAPS review,” Journal of Pediatric Surgery, vol. 18, no. 1, pp. 70–74, 1983.
[4]
A. J. Casale, “Early ureteral surgery for posterior urethral valves,” Urologic Clinics of North America, vol. 17, no. 2, pp. 361–372, 1990.
[5]
J. S. Elder, “Management of antenatally detected hydronephrosis,” in Newborn Surgery, P. Puri, Ed., pp. 793–808, Hodder Arnold, London, UK, 2nd edition, 2003.
[6]
K. S. Roth, W. H. Carter Jr., and J. C. M. Chan, “Obstructive nephropathy in children: long-term progression after relief of posterior urethral valve,” Pediatrics, vol. 107, no. 5, pp. 1004–1010, 2001.
[7]
H. F. Parkhouse, T. M. Barratt, M. J. Dillon et al., “Long-term outcome of boys with posterior urethral valves,” British Journal of Urology, vol. 62, no. 1, pp. 59–62, 1988.
[8]
W. DeFoor, C. Clark, E. Jackson, P. Reddy, E. Minevich, and C. Sheldon, “Risk factors for end stage renal disease in children with posterior urethral valves,” Journal of Urology, vol. 180, no. 4, pp. 1705–1708, 2008.
[9]
Y. Reinberg, I. de Castano, and R. Gonzalez, “Prognosis for patients with prenatally diagnosed posterior urethral valves,” Journal of Urology, vol. 148, no. 1, pp. 125–126, 1992.
[10]
G. H. H. Smith, D. A. Canning, S. L. Schulman, H. M. Snyder, and J. W. Duckett, “The long-term outcome of posterior urethral valves treated with primary valve ablation and observation,” Journal of Urology, vol. 155, no. 5, pp. 1730–1734, 1996.
[11]
I. Anochie and F. Eke, “Obstructive uropathy in childhood, as seen in University of Port Harcourt Teaching Hospital, Nigeria,” Nigerian Journal of Medicine, vol. 13, no. 2, pp. 136–139, 2004.
[12]
A. S. Woolf and N. Thiruchelvam, “Congenital obstructive uropathy: its origin and contribution to end-stage renal disease in children,” Advances in Renal Replacement Therapy, vol. 8, no. 3, pp. 157–163, 2001.
[13]
B. A. Okoro and H. U. Okafor, “Pattern of childhood renal disorder in Enugu Nigeria,” Nigerian Journal of Pediatrics, vol. 26, no. 1, pp. 14–18, 1999.
[14]
F. U. Eke and N. N. Eke, “Renal disorders in children: a Nigerian study,” Pediatric Nephrology, vol. 8, no. 3, pp. 383–386, 1994.
[15]
I. S. Etuk, M. U. Anah, S. O. Ochighs, and M. Eyong, “Pattern of paediatric renal disease in inpatients in Calabar, Nigeria,” Tropical Doctor, vol. 36, no. 4, article 256, 2006.
[16]
K. A. R. Hutton, D. F. M. Thomas, R. J. Arthur, H. C. Irving, and S. E. W. Smith, “Prenatally detected posterior urethral valves: is gestational age at detection a predictor of outcome?” Journal of Urology, vol. 152, no. 2, pp. 698–701, 1994.
[17]
“ACOG practice bulletin no. 101: ultrasonography in pregnancy,” vol. 113, no. 2, part 1, pp. 451–461, 2009.
[18]
M. D. Dinneen, H. K. Dhillon, H. C. Ward, P. G. Duffy, and P. G. Ransley, “Antenatal diagnosis of posterior urethral valves,” British Journal of Urology, vol. 72, no. 3, pp. 364–369, 1993.
[19]
C. C. Ohagwu, P. O. Abu, M. C. Odo, and H. U. Chiegwu, “Maternal perception of barriers to utilization of prenatal ultrasound in prenatal care in the Northern part of Nigeria,” Clinic in Mother and Child Health, vol. 7, no. 1, pp. 1195–1199, 2010.
[20]
E. D. Denes, J. S. Barthold, and R. González, “Early prognostic value of serum creatinine levels in children with posterior urethral valves,” Journal of Urology, vol. 157, no. 4, pp. 1441–1443, 1997.
[21]
B. Akdogan, H. S. Dogan, S. Keskin, B. Burgu, and S. Tekgul, “Significance of age-specific creatinine levels at presentation in posterior urethral valve patients,” Journal of Pediatric Urology, vol. 2, no. 5, pp. 446–452, 2006.
[22]
P. Lopez Pereira, L. Espinosa, M. J. Martinez Urrutina, R. Lobato, M. Navarro, and E. Jaureguizar, “Posterior urethral valves: prognostic factors,” British Journal of Urology International, vol. 91, no. 7, pp. 687–690, 2003.
[23]
S. K. Chowdhary, D. T. Wilcox, and P. G. Ransley, “Posterior urethral valves: antenatal diagnosis and management,” Journal of Indian Association of Paediatric Surgeon, vol. 8, no. 3, pp. 163–168, 2003.
[24]
E. Ylinen, M. Ala-Houhala, and S. Wikstr？m, “Prognostic factors of posterior urethral valves and the role of antenatal detection,” Pediatric Nephrology, vol. 19, no. 8, pp. 874–879, 2004.
[25]
A. O. Asinobi, R. A. Gbadegesin, and O. B. Shittu, “A review of cases of posterior urethral valves seen at the University College Hospital, Ibadan (Nigeria),” La Pediatria Medica e Chirurgica, vol. 26, no. 6, pp. 430–433, 2004.
[26]
J. Warren, J. G. Pike, and M. P. Leonard, “Posterior urethral valves in Eastern Ontario—30 year perspective,” The Canadian Journal of Urology, vol. 11, no. 2, pp. 2210–2215, 2004.
[27]
M. T. El-Sherbiny, A. T. Hafez, and A. A. Shokeir, “Posterior urethral valves: does young age at diagnosis correlate with poor renal function?” Urology, vol. 60, no. 2, pp. 335–338, 2002.
[28]
M. D. Bomalaski, J. G. Anema, D. E. Coplen, H. P. Koo, T. Rozanski, and D. A. Bloom, “Delayed presentation of posterior urethral valves: a not so benign condition,” Journal of Urology, vol. 162, no. 6, pp. 2130–2132, 1999.
